PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells

Allali-Hassani, 2009, A survey of proteins encoded by non-synonymous single nucleotide polymorphisms reveals a significant fraction with altered stability and activity, Biochem. J., 424, 15, 10.1042/BJ20090723 Anastasiou, 2011, Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses, Science, 334, 1278, 10.1126/science.1211485 Anastasiou, 2012, Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis, Nat. Chem. Biol., 8, 839, 10.1038/nchembio.1060 Ayala, 2010, Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice, Dis. Model. Mech., 3, 525, 10.1242/dmm.006239 Baumhoer, 2008, Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples, Am. J. Clin. Pathol., 129, 899, 10.1309/HCQWPWD50XHD2DW6 Cairns, 2011, Regulation of cancer cell metabolism, Nat. Rev. Cancer, 11, 85, 10.1038/nrc2981 Cerami, 2012, The cBiol. cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov., 2, 401, 10.1158/2159-8290.CD-12-0095 Chaneton, 2012, Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer, Trends Biochem. Sci., 37, 309, 10.1016/j.tibs.2012.04.003 Chaneton, 2012, Serine is a natural ligand and allosteric activator of pyruvate kinase M2, Nature, 491, 458, 10.1038/nature11540 Chen, 2012, Concentration-dependent control of pyruvate kinase M mutually exclusive splicing by hnRNP proteins, Nat. Struct. Mol. Biol., 19, 346, 10.1038/nsmb.2219 Christofk, 2008, The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth, Nature, 452, 230, 10.1038/nature06734 Christofk, 2008, Pyruvate kinase M2 is a phosphotyrosine-binding protein, Nature, 452, 181, 10.1038/nature06667 Clower, 2010, The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism, Proc. Natl. Acad. Sci. USA, 107, 1894, 10.1073/pnas.0914845107 Commisso, 2013, Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells, Nature, 497, 633, 10.1038/nature12138 Cortés-Cros, 2013, M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth, Proc. Natl. Acad. Sci. USA, 110, 489, 10.1073/pnas.1212780110 David, 2010, HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer, Nature, 463, 364, 10.1038/nature08697 Dombrauckas, 2005, Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis, Biochemistry, 44, 9417, 10.1021/bi0474923 Gao, 2012, Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase, Mol. Cell, 45, 598, 10.1016/j.molcel.2012.01.001 Goldberg, 2012, Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression, J. Exp. Med., 209, 217, 10.1084/jem.20111487 Hitosugi, 2009, Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth, Sci. Signal., 2, ra73, 10.1126/scisignal.2000431 Imamura, 1972, Multimolecular forms of pyruvate kinase from rat and other mammalian tissues. I. Electrophoretic studies, J. Biochem., 71, 1043, 10.1093/oxfordjournals.jbchem.a129852 Jain, 2012, Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation, Science, 336, 1040, 10.1126/science.1218595 Jurczak, 2012, Dissociation of inositol-requiring enzyme (IRE1α)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice, J. Biol. Chem., 287, 2558, 10.1074/jbc.M111.316760 Keller, 2012, SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions, Science, 338, 1069, 10.1126/science.1224409 Liang, 2012, Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer, Genome Res., 22, 2120, 10.1101/gr.137596.112 Luo, 2011, Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1, Cell, 145, 732, 10.1016/j.cell.2011.03.054 Lv, 2011, Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth, Mol. Cell, 42, 719, 10.1016/j.molcel.2011.04.025 Maquat, 2004, Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics, Nat. Rev. Mol. Cell Biol., 5, 89, 10.1038/nrm1310 Mazurek, 2011, Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells, Int. J. Biochem. Cell Biol., 43, 969, 10.1016/j.biocel.2010.02.005 Noguchi, 1986, The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing, J. Biol. Chem., 261, 13807, 10.1016/S0021-9258(18)67091-7 Parnell, 2013, Pharmacologic activation of PKM2 slows lung tumor Xenograft growth, Mol. Cancer Ther., 12, 1453, 10.1158/1535-7163.MCT-13-0026 Salk, 2010, Mutational heterogeneity in human cancers: origin and consequences, Annu. Rev. Pathol., 5, 51, 10.1146/annurev-pathol-121808-102113 Schraml, 1999, Tissue microarrays for gene amplification surveys in many different tumor types, Clin. Cancer Res., 5, 1966 Sonveaux, 2008, Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice, J. Clin. Invest., 118, 3930 Vander Heiden, 2001, Growth factors can influence cell growth and survival through effects on glucose metabolism, Mol. Cell. Biol., 21, 5899, 10.1128/MCB.21.17.5899-5912.2001 Vander Heiden, 2009, Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science, 324, 1029, 10.1126/science.1160809 Vander Heiden, 2010, Evidence for an alternative glycolytic pathway in rapidly proliferating cells, Science, 329, 1492, 10.1126/science.1188015 Varghese, 2010, Prolactin inhibits activity of pyruvate kinase M2 to stimulate cell proliferation, Mol. Endocrinol., 24, 2356, 10.1210/me.2010-0219 Vaupel, 1989, Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review, Cancer Res., 49, 6449 Wang, 2012, Exon-centric regulation of pyruvate kinase M alternative splicing via mutually exclusive exons, J. Mol. Cell Biol., 4, 79, 10.1093/jmcb/mjr030 Xu, 1999, Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation, Nat. Genet., 22, 37, 10.1038/8743 Yang, 2011, Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation, Nature, 480, 118, 10.1038/nature10598 Yang, 2012, PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis, Cell, 150, 685, 10.1016/j.cell.2012.07.018 Yang, 2012, ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect, Nat. Cell Biol., 14, 1295, 10.1038/ncb2629 Bardeesy, 2002, Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation, Nature, 419, 162, 10.1038/nature01045 Raymond, 2007, High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells, PLoS ONE, 2, e162, 10.1371/journal.pone.0000162 Wang, 1994, SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis, Cell, 77, 53, 10.1016/0092-8674(94)90234-8